T1	Participants 478 600	Consecutive post-menopausal women aged 50 years to 86 years starting treatment with raloxifene according to daily practice
T2	Participants 931 1028	A total of 745 post-menopausal women (group A, n=366; group B n=379), with a mean age of 62 years
